Evidence map›Paper›PMID 36201072›Full record

ArticleEJNMMI radiopharmacy and chemistry2022

A closer look at the synthesis of 2-[

Martha Sahylí Ortega Pijeira, Sofia Nascimento Dos Santos, Yasniel Babi Araujo, André Luis Lapolli, Marcio Nardelli Wandermuren, Zalua Rodríguez Riera, Ivone Carvalho, Philip H Elsinga, Emerson Soares Bernardes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Martha Sahylí Ortega PijeiraInstituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP), São Paulo, SP, CEP 05508-000, Brazil.
Sofia Nascimento Dos SantosInstituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP), São Paulo, SP, CEP 05508-000, Brazil.
Yasniel Babi AraujoInstituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP), São Paulo, SP, CEP 05508-000, Brazil.
André Luis LapolliInstituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP), São Paulo, SP, CEP 05508-000, Brazil.
Marcio Nardelli WandermurenChemistry Institute, University of São Paulo, São Paulo, SP, CEP 05508-000, Brazil.
Zalua Rodríguez RieraDepartamento de Radioquímica, Instituto Superior de Tecnologías y Ciencias Aplicadas (InSTEC), Universidad de La Habana, 10400, Havana, Cuba.
Ivone CarvalhoSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, CEP 14040-903, Brazil.
Philip H ElsingaDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Emerson Soares BernardesInstituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP), São Paulo, SP, CEP 05508-000, Brazil. ebernardes@ipen.br.ORCID http://orcid.org/0000-0002-0029-7313

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2012/06875-6
6 · The paper itself

Abstract

background2-[

resultsIn order to characterize the volatiles produced during [

conclusion[

Indexed as

[18F]vinyl fluoride2-[18F]fluoroethanol2-[18F]Fluoroethyl tosylatePET tracersRadiation safetyRadioactive gas

Identifiers

PMID36201072
PMCPMC9537402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.